Elysium Pharmaceuticals has recently filed its DRHP with SEBI on , for th issue of 66,98,250 equity shares of Rs 10 each at a premium per share at an Issue price in the price band of Rs 25 to 28. The IPO would constitute 32.67% of the fully diluted post issue paid up capital of the company.

The Equity Shares offered through this IPO are proposed to be listed on the BSE. The BRLM's are Canara Bank and Allbank Finance Limited.

Elysium pharmaceuticals Ltd was incorporated in the year 1995 as a formulation unit and later started manufacturing operations in the year 1997.The Company is involved in manufacturing of sterile formulations like Liquid and Dry Parenterals, and non-sterile formulations like Tablets, Capsules, Liquid orals,Ointment, Dry Syrups etc under third party and Contract Manufacturing segment for established Pharma Companies (Bayer,Zydus Cadila,Elder Pharma,Aventis,Torrent,Nicholas Piramal) and Produces its own products Viz.drugs under Ethical segment.

The company plans to use the funds from the IPO for Setting up a MHRA plant and to partially repay existing long term secured debt.